Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Autoimmunity 1 Year Later: The Era of Vaccines
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Autoimmunity 1 Year Later: The Era of Vaccines
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-10-01
DOI
10.3389/fimmu.2021.708848
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19
- (2021) Robert L. Gottlieb et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine
- (2021) Jerald Sadoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial
- (2021) Serge Bureau et al. Lancet Respiratory Medicine
- Immunomodulatory therapies for SARS-CoV-2 infection: a systematic literature review to inform EULAR points to consider
- (2021) Alessia Alunno et al. ANNALS OF THE RHEUMATIC DISEASES
- Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study
- (2021) Hannah Bower et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinical outcomes of COVID-19 in patients with rheumatic diseases: A systematic review and meta-analysis of global data
- (2021) Chuanhui Xu et al. AUTOIMMUNITY REVIEWS
- Extremely potent human monoclonal antibodies from COVID-19 convalescent patients
- (2021) Emanuele Andreano et al. CELL
- Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19
- (2021) Kathryn E. Stephenson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Coronavirus disease 2019, immune-mediated inflammatory diseases and immunosuppressive therapies – A Danish population-based cohort study
- (2021) Mohamed Attauabi et al. JOURNAL OF AUTOIMMUNITY
- Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
- (2021) Denis Y Logunov et al. LANCET
- Sputnik V COVID-19 vaccine candidate appears safe and effective
- (2021) Ian Jones et al. LANCET
- Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial
- (2021) Raches Ella et al. LANCET INFECTIOUS DISEASES
- Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera
- (2021) Xuping Xie et al. NATURE MEDICINE
- Baricitinib Therapy in Covid-19 Pneumonia — An Unmet Need Fulfilled
- (2021) Delia Goletti et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia
- (2021) Ivan O. Rosas et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
- (2021) NEW ENGLAND JOURNAL OF MEDICINE
- Systematic review and meta-analysis of anakinra, sarilumab, siltuximab and tocilizumab for COVID-19
- (2021) Fasihul A Khan et al. THORAX
- An open label trial of anakinra to prevent respiratory failure in COVID-19
- (2021) Evdoxia Kyriazopoulou et al. eLife
- The Rheumatology Drugs for COVID-19 Management: Which and When?
- (2021) Fabiola Atzeni et al. Journal of Clinical Medicine
- SARS-CoV-2 vaccination responses in untreated, conventionally treated and anticytokine-treated patients with immune-mediated inflammatory diseases
- (2021) David Simon et al. ANNALS OF THE RHEUMATIC DISEASES
- Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort
- (2021) Ulf M Geisen et al. ANNALS OF THE RHEUMATIC DISEASES
- Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study
- (2021) Victoria Furer et al. ANNALS OF THE RHEUMATIC DISEASES
- Response to: Correspondence on “SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response” by Bonelli et al
- (2021) Michael Bonelli et al. ANNALS OF THE RHEUMATIC DISEASES
- American College of Rheumatology Guidance for COVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 2
- (2021) Jeffrey R. Curtis et al. Arthritis & Rheumatology
- Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial
- (2021) Jean-Claude Tardif et al. Lancet Respiratory Medicine
- ImmunosuppressiveTherapies Differently Modulate Humoral- and T-Cell-Specific Responses to COVID-19 mRNA Vaccine in Rheumatoid Arthritis Patients
- (2021) Andrea Picchianti-Diamanti et al. Frontiers in Immunology
- Tolerance of COVID-19 vaccination in patients with systemic lupus erythematosus: the international VACOLUP study
- (2021) Renaud Felten et al. Lancet Rheumatology
- Baricitinib as potential treatment for 2019-nCoV acute respiratory disease
- (2020) Peter Richardson et al. LANCET
- Convalescent plasma in Covid-19: Possible mechanisms of action
- (2020) Manuel Rojas et al. AUTOIMMUNITY REVIEWS
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China
- (2020) Wen Zhang et al. CLINICAL IMMUNOLOGY
- Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
- (2020) Chuan Qin et al. CLINICAL INFECTIOUS DISEASES
- Cytokine Release Syndrome in COVID-19 Patients, A New Scenario for an Old Concern: The Fragile Balance between Infections and Autoimmunity
- (2020) Andrea Picchianti Diamanti et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Clinical and immunological features of severe and moderate coronavirus disease 2019
- (2020) Guang Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact
- (2020) Fabrizio Cantini et al. JOURNAL OF INFECTION
- Effective treatment of severe COVID-19 patients with tocilizumab
- (2020) Xiaoling Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies
- (2020) Jianjun Gao et al. BioScience Trends
- Low‐dose hydrocortisone in patients with COVID‐19 and severe hypoxia (COVID STEROID) trial—Protocol and statistical analysis plan
- (2020) Marie Warrer Petersen et al. ACTA ANAESTHESIOLOGICA SCANDINAVICA
- EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2
- (2020) Robert BM Landewé et al. ANNALS OF THE RHEUMATIC DISEASES
- Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2
- (2020) Hui Wang et al. CELL
- Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients’ B Cells
- (2020) Yunlong Cao et al. CELL
- COVID‐19 vaccine‐readiness for anti‐CD20‐depleting therapy in autoimmune diseases
- (2020) D. Baker et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Analysis of a SARS-CoV-2-Infected Individual Reveals Development of Potent Neutralizing Antibodies with Limited Somatic Mutation
- (2020) Emilie Seydoux et al. IMMUNITY
- Beneficial impact of Baricitinib in COVID-19 moderate pneumonia; multicentre study
- (2020) Fabrizio Cantini et al. JOURNAL OF INFECTION
- Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
- (2020) Pedro M Folegatti et al. LANCET
- Phase 1/2 study of COVID-19 RNA vaccine BNT162b1 in adults
- (2020) Mark J. Mulligan et al. NATURE
- SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls
- (2020) Nina Le Bert et al. NATURE
- Convergent antibody responses to SARS-CoV-2 in convalescent individuals
- (2020) Davide F. Robbiani et al. NATURE
- Next-generation vaccine platforms for COVID-19
- (2020) Debby van Riel et al. NATURE MATERIALS
- An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
- (2020) Lisa A. Jackson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Early IL-1 receptor blockade in severe inflammatory respiratory failure complicating COVID-19
- (2020) Raphaël Cauchois et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Patients with MS treated with immunosuppressive agents: Across the COVID-19 spectrum
- (2020) C. Louapre et al. REVUE NEUROLOGIQUE
- Anti-CD20 and COVID-19 in multiple sclerosis and related disorders: A case series of 60 patients from Madrid, Spain
- (2020) Paloma Montero-Escribano et al. Multiple Sclerosis and Related Disorders
- Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019
- (2020) Spyridon G. Deftereos et al. JAMA Network Open
- Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
- (2020) Takuya Sekine et al. CELL
- Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19
- (2020) Naoki Kaneko et al. CELL
- Comparative Survival Analysis of Immunomodulatory Therapy for COVID-19 'Cytokine Storm'
- (2020) Sonali Narain et al. CHEST
- Immune Therapy, or Antiviral Therapy, or Both for COVID-19: A Systematic Review
- (2020) Fabrizio Cantini et al. DRUGS
- Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19
- (2020) Pierre-François Dequin et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19
- (2020) Bruno M. Tomazini et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19
- (2020) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial
- (2020) Shengli Xia et al. LANCET INFECTIOUS DISEASES
- Convalescent plasma treatment of severe COVID-19: a propensity score–matched control study
- (2020) Sean T. H. Liu et al. NATURE MEDICINE
- Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
- (2020) Edward E. Walsh et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of dexamethasone treatment for patients with the acute respiratory distress syndrome caused by COVID-19: study protocol for a randomized controlled superiority trial
- (2020) Jesús Villar et al. Trials
- Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac – PROFISCOV: A structured summary of a study protocol for a randomised controlled trial
- (2020) Ricardo Palacios et al. Trials
- Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia
- (2020) Olivier Hermine et al. JAMA Internal Medicine
- Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia
- (2020) Carlo Salvarani et al. JAMA Internal Medicine
- Colchicine to Weather the Cytokine Storm in Hospitalized Patients with COVID-19
- (2020) Luigi Brunetti et al. Journal of Clinical Medicine
- Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses
- (2020) Rinke Bos et al. npj Vaccines
- Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production
- (2020) Yuezhou Chen et al. CELL
- Rational development of a human antibody cocktail that deploys multiple functions to confer Pan-SARS-CoVs protection
- (2020) Hangping Yao et al. CELL RESEARCH
- Structure-based development of human antibody cocktails against SARS-CoV-2
- (2020) Nan Wang et al. CELL RESEARCH
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- (2020) Merryn Voysey et al. LANCET
- Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
- (2020) Maheshi N Ramasamy et al. LANCET
- The COVID-19 pandemic: consequences for nephrology
- (2020) Annette Bruchfeld Nature Reviews Nephrology
- Rheumatic disease and COVID-19: epidemiology and outcomes
- (2020) Kimme L. Hyrich et al. Nature Reviews Rheumatology
- A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19
- (2020) Peter Chen et al. NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19 in patients with systemic lupus erythematosus: lessons learned from the inflammatory disease
- (2020) Ruth Fernandez-Ruiz et al. Translational Research
- Anakinra in hospitalized patients with severe COVID-19 pneumonia requiring oxygen therapy: Results of a prospective, open-label, interventional study
- (2020) A. Balkhair et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
- (2020) Yanjun Zhang et al. LANCET INFECTIOUS DISEASES
- Selective JAKinibs: Prospects in Inflammatory and Autoimmune Diseases
- (2019) Anniina T. Virtanen et al. BIODRUGS
- 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases
- (2019) Victoria Furer et al. ANNALS OF THE RHEUMATIC DISEASES
- Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry
- (2019) Yushun Wan et al. JOURNAL OF VIROLOGY
- Impact of temporary methotrexate discontinuation for 2 weeks on immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial
- (2018) Jin Kyun Park et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinical characteristics and risk factors of infections in patients with systemic lupus erythematosus
- (2018) Chengcheng Hou et al. CLINICAL RHEUMATOLOGY
- Self-Amplifying Replicon RNA Delivery to Dendritic Cells by Cationic Lipids
- (2018) Pavlos C. Englezou et al. Molecular Therapy-Nucleic Acids
- Update on colchicine, 2017
- (2017) Anastasia Slobodnick et al. RHEUMATOLOGY
- Methotrexate reduces vaccine-specific immunoglobulin levels but not numbers of circulating antibody-producing B cells in rheumatoid arthritis after vaccination with a conjugate pneumococcal vaccine
- (2017) Meliha C. Kapetanovic et al. VACCINE
- Review: Cytokine Storm Syndrome: Looking Toward the Precision Medicine Era
- (2017) Edward M. Behrens et al. Arthritis & Rheumatology
- Therapeutic management of patients with rheumatoid arthritis and associated interstitial lung disease: case report and literature review
- (2016) Andrea Picchianti Diamanti et al. Therapeutic Advances in Respiratory Disease
- The effect of tofacitinib on pneumococcal and influenza vaccine responses in rheumatoid arthritis
- (2015) Kevin L Winthrop et al. ANNALS OF THE RHEUMATIC DISEASES
- Opsonic and Antibody Responses to Pneumococcal Polysaccharide in Rheumatoid Arthritis Patients Receiving Golimumab Plus Methotrexate
- (2015) Kiyoshi Migita et al. MEDICINE
- Colchicine—Update on mechanisms of action and therapeutic uses
- (2015) Ying Ying Leung et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Effect of abatacept on the immunogenicity of 23-valent pneumococcal polysaccharide vaccination (PPSV23) in rheumatoid arthritis patients
- (2015) Kiyoshi Migita et al. ARTHRITIS RESEARCH & THERAPY
- Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tacrolimus
- (2015) Kiyoshi Migita et al. ARTHRITIS RESEARCH & THERAPY
- Humoral immune response to vaccines in patients with rheumatoid arthritis treated with tocilizumab: results of a randomised controlled trial (VISARA)
- (2014) Clifton O Bingham et al. ANNALS OF THE RHEUMATIC DISEASES
- Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins
- (2014) Sheng-Fan Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Safety and immunogenicity of co-administered MF59-adjuvanted 2009 pandemic and plain 2009-10 seasonal influenza vaccines in rheumatoid arthritis patients on biologicals
- (2014) F. Milanetti et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Investigation of clinical characteristics as predictive factors for the humoral immune response to the influenza vaccine in patients with rheumatoid arthritis
- (2014) Toshiaki Kogure et al. CLINICAL RHEUMATOLOGY
- Infection risk in Rheumatoid Arthritis and Spondyloarthropathy patients under treatment with DMARDs, Corticosteroids and TNF-α antagonists
- (2014) Valentina Germano et al. Journal of Translational Medicine
- Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis
- (2014) Meliha C Kapetanovic et al. ARTHRITIS RESEARCH & THERAPY
- Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tocilizumab therapy
- (2013) Shunsuke Mori et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinical Assessment of a Novel Recombinant Simian Adenovirus ChAdOx1 as a Vectored Vaccine Expressing Conserved Influenza A Antigens
- (2013) Richard D Antrobus et al. MOLECULAR THERAPY
- High Disease Activity: An Independent Factor for Reduced Immunogenicity of the Pandemic Influenza A Vaccine in Patients With Juvenile Systemic Lupus Erythematosus
- (2013) Lucia M. A. Campos et al. ARTHRITIS CARE & RESEARCH
- Effect of Methotrexate, Anti-Tumor Necrosis Factor α, and Rituximab on the Immune Response to Influenza and Pneumococcal Vaccines in Patients With Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
- (2013) Charlotte Hua et al. ARTHRITIS CARE & RESEARCH
- Rituximab and abatacept but not tocilizumab impair antibody response to pneumococcal conjugate vaccine in patients with rheumatoid arthritis
- (2013) Meliha Crnkic Kapetanovic et al. ARTHRITIS RESEARCH & THERAPY
- Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: Comparison of adalimumab, etanercept and infliximab in the GISEA registry
- (2012) Fabiola Atzeni et al. AUTOIMMUNITY REVIEWS
- Jakinibs: a new class of kinase inhibitors in cancer and autoimmune disease
- (2012) Apostolos Kontzias et al. CURRENT OPINION IN PHARMACOLOGY
- Into the Eye of the Cytokine Storm
- (2012) J. R. Tisoncik et al. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
- Influenza A/H1N1 vaccination of patients with SLE: can antimalarial drugs restore diminished response under immunosuppressive therapy?
- (2012) E. F. Borba et al. RHEUMATOLOGY
- New insights into chronic inflammation-induced immunosuppression
- (2012) Julia Kanterman et al. SEMINARS IN CANCER BIOLOGY
- Abatacept and reduced immune response to pandemic 2009 influenza A/H1N1 vaccination in patients with rheumatoid arthritis
- (2012) Ana C. Ribeiro et al. ARTHRITIS CARE & RESEARCH
- Immunogenicity and safety of the 2009 non-adjuvanted influenza A/H1N1 vaccine in a large cohort of autoimmune rheumatic diseases
- (2011) C. G. S. Saad et al. ANNALS OF THE RHEUMATIC DISEASES
- Pneumococcal antibody levels after pneumovax in patients with rheumatoid arthritis on methotrexate
- (2011) E. Coulson et al. ANNALS OF THE RHEUMATIC DISEASES
- Reduced seroprotection after pandemic H1N1 influenza adjuvant-free vaccination in patients with rheumatoid arthritis: implications for clinical practice
- (2011) A. C. M. Ribeiro et al. ANNALS OF THE RHEUMATIC DISEASES
- Influenza vaccination responses in human systemic lupus erythematosus: Impact of clinical and demographic features
- (2011) Sherry R. Crowe et al. ARTHRITIS AND RHEUMATISM
- Protective effect of A/H1N1 vaccination in immune-mediated disease--a prospectively controlled vaccination study
- (2011) S. Adler et al. RHEUMATOLOGY
- The cellular immune response to influenza vaccination is preserved in rheumatoid arthritis patients treated with rituximab
- (2011) U. Arad et al. VACCINE
- Efficacy and safety of vaccination against pandemic 2009 influenza A (H1N1) virus among patients with rheumatic diseases
- (2011) Ori Elkayam et al. ARTHRITIS CARE & RESEARCH
- Decreased influenza-specific B cell responses in rheumatoid arthritis patients treated with anti-tumor necrosis factor
- (2011) James J Kobie et al. ARTHRITIS RESEARCH & THERAPY
- The association between systemic glucocorticoid therapy and the risk of infection in patients with rheumatoid arthritis: systematic review and meta-analyses
- (2011) William G Dixon et al. ARTHRITIS RESEARCH & THERAPY
- Influenza vaccine administration in rheumatoid arthritis patients under treatment with TNFα blockers: Safety and immunogenicity
- (2009) S. Salemi et al. CLINICAL IMMUNOLOGY
- Vaccines: Vaccination in Patients with Chronic Rheumatic or Autoimmune Diseases
- (2008) T. Glück et al. CLINICAL INFECTIOUS DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now